X
Xenocs
Helping customers in their research, development, and production of advanced materials, through solutions for characterization at the nanoscale
About Xenocs
Xenocs specializes in providing advanced nanoscale characterization solutions through Small and Wide Angle X-ray Scattering (SAXS and WAXS) technologies. The company serves a diverse range of clients including academic institutions, research centers, and industrial laboratories engaged in the research, development, and production of advanced materials. Operating in the scientific instrumentation market, Xenocs offers a suite of products such as the Xeuss 3.0, BioXolver, and Nano inXider, which are designed to facilitate detailed structural analysis at the nanoscale. The business model revolves around the sale and installation of these high-precision instruments, along with offering complementary services such as maintenance, training, and application support. Revenue is primarily generated through the direct sale of instruments and ongoing service contracts. With over 170 X-ray scattering instruments installed since 2012 and 1,800 customer publications in the last five years, Xenocs has established itself as a key player in the field of nanoscale characterization.
Source: Dealroom company dataAt a glance
- Founded
- 2000
- Headquarters
- Grenoble, France
- Sector
- Energy
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
CAPZA
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Xenocs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Xenocs on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.